214 related articles for article (PubMed ID: 25762620)
1. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
[TBL] [Abstract][Full Text] [Related]
2. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
[TBL] [Abstract][Full Text] [Related]
3. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
[TBL] [Abstract][Full Text] [Related]
4. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
[TBL] [Abstract][Full Text] [Related]
5. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
[TBL] [Abstract][Full Text] [Related]
6. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
7. Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
Wang Y; Liao X; Ye Q; Huang L
Sci China Life Sci; 2018 Nov; 61(11):1389-1395. PubMed ID: 30076562
[TBL] [Abstract][Full Text] [Related]
8. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
[TBL] [Abstract][Full Text] [Related]
9. C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
Chou CH; Huang MJ; Liao YY; Chen CH; Huang MC
Int J Gynecol Cancer; 2017 Jun; 27(5):863-871. PubMed ID: 28498248
[TBL] [Abstract][Full Text] [Related]
10. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
[TBL] [Abstract][Full Text] [Related]
11. Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.
Milde-Langosch K; Schütze D; Oliveira-Ferrer L; Wikman H; Müller V; Lebok P; Pantel K; Schröder C; Witzel I; Schumacher U
Breast Cancer Res Treat; 2015 Jun; 151(3):515-28. PubMed ID: 25975956
[TBL] [Abstract][Full Text] [Related]
12. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
[TBL] [Abstract][Full Text] [Related]
14. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma.
Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L
Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977
[TBL] [Abstract][Full Text] [Related]
15. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
[TBL] [Abstract][Full Text] [Related]
16. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
[TBL] [Abstract][Full Text] [Related]
17. Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer.
Lin NY; Lee JJ; Chen ST; Lin JA; Lin CH; Lin HY; Su YH; Chen CC; Lin MC; Kuo CY; Huang MC
Mol Cancer Res; 2023 Jul; 21(7):664-674. PubMed ID: 37040171
[TBL] [Abstract][Full Text] [Related]
18. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
19. Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer.
Udhayakumar G; Jayanthi V; Devaraj N; Devaraj H
Mol Carcinog; 2007 Sep; 46(9):807-17. PubMed ID: 17393422
[TBL] [Abstract][Full Text] [Related]
20. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Chugh S; Barkeer S; Rachagani S; Nimmakayala RK; Perumal N; Pothuraju R; Atri P; Mahapatra S; Thapa I; Talmon GA; Smith LM; Yu X; Neelamegham S; Fu J; Xia L; Ponnusamy MP; Batra SK
Gastroenterology; 2018 Nov; 155(5):1608-1624. PubMed ID: 30086262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
